Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Checkmate Pharmaceuticals, Inc. (CMPI) since 2020 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Checkmate Pharmaceuticals, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1651431.
Total stock buying since 2020: $13,457,915.
Total stock sales since 2020: $15,776,580.
Total stock option exercises since 2020: $20,960.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2022 | 0 | $0 | 1,517,444 | $15,776,580 | 0 | $0 |
| 2021 | 84,744 | $806,084 | 0 | $0 | 4,000 | $10,480 |
| 2020 | 843,726 | $12,651,831 | 0 | $0 | 4,000 | $10,480 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2022-05 | 0 | $0 | 649,903 | $6,755,700 | 0 | $0 |
| 2022-04 | 0 | $0 | 867,541 | $9,020,880 | 0 | $0 |
| 2021-06 | 10,802 | $65,744 | 0 | $0 | 0 | $0 |
| 2021-05 | 25,001 | $174,256 | 0 | $0 | 0 | $0 |
| 2021-03 | 46,740 | $537,341 | 0 | $0 | 0 | $0 |
| 2021-02 | 0 | $0 | 0 | $0 | 2,000 | $5,240 |
| 2021-01 | 2,201 | $28,743 | 0 | $0 | 2,000 | $5,240 |
| 2020-12 | 10,393 | $151,836 | 0 | $0 | 4,000 | $10,480 |
| 2020-08 | 833,333 | $12,499,995 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-05-16 | Adelman Robert J | Sale | 95,800 | 10.45 | 1,001,109 |
| 2022-05-13 | Adelman Robert J | Sale | 35,850 | 10.45 | 374,453 |
| 2022-05-12 | Adelman Robert J | Sale | 124,525 | 10.39 | 1,294,312 |
| 2022-05-11 | Adelman Robert J | Sale | 17,700 | 10.38 | 183,637 |
| 2022-05-10 | Adelman Robert J | Sale | 18,676 | 10.38 | 193,875 |
| 2022-05-09 | Adelman Robert J | Sale | 17,600 | 10.37 | 182,582 |
| 2022-05-06 | Adelman Robert J | Sale | 48,334 | 10.37 | 501,223 |
| 2022-05-05 | Adelman Robert J | Sale | 20,743 | 10.37 | 215,104 |
| 2022-05-04 | Adelman Robert J | Sale | 37,500 | 10.37 | 388,912 |
| 2022-05-03 | Adelman Robert J | Sale | 79,475 | 10.37 | 824,473 |
| 2022-05-02 | Adelman Robert J | Sale | 153,700 | 10.38 | 1,596,020 |
| 2022-04-29 | Adelman Robert J | Sale | 69,230 | 10.38 | 718,676 |
| 2022-04-28 | Adelman Robert J | Sale | 73,400 | 10.38 | 761,965 |
| 2022-04-27 | Adelman Robert J | Sale | 47,396 | 10.38 | 491,970 |
| 2022-04-26 | Adelman Robert J | Sale | 64,683 | 10.38 | 671,538 |
| 2022-04-25 | Adelman Robert J | Sale | 27,668 | 10.39 | 287,415 |
| 2022-04-22 | Adelman Robert J | Sale | 37,430 | 10.39 | 388,822 |
| 2022-04-21 | Adelman Robert J | Sale | 62,200 | 10.38 | 645,884 |
| 2022-04-20 | Adelman Robert J | Sale | 85,611 | 10.39 | 889,412 |
| 2022-04-19 | Adelman Robert J | Sale | 399,923 | 10.41 | 4,165,198 |
| 2021-06-18 | Krieg Arthur M (Chief Scientific Officer) | Buy | 7,224 | 6.04 | 43,632 |
| 2021-06-16 | Krieg Arthur M (Chief Scientific Officer) | Buy | 3,578 | 6.18 | 22,112 |
| 2021-05-18 | Krieg Arthur M (Chief Scientific Officer) | Buy | 25,001 | 6.97 | 174,256 |
| 2021-03-29 | Krieg Arthur M (Chief Scientific Officer) | Buy | 33,220 | 11.17 | 371,067 |
| 2021-03-26 | Krieg Arthur M (Chief Scientific Officer) | Buy | 3,484 | 12.15 | 42,330 |
| 2021-03-25 | Krieg Arthur M (Chief Scientific Officer) | Buy | 10,036 | 12.35 | 123,944 |
| 2021-02-26 | Chaudhary Kleem (Chief Business Officer) | Option Ex | 2,000 | 2.62 | 5,240 |
| 2021-01-27 | Krieg Arthur M (Chief Scientific Officer) | Buy | 1,701 | 13.05 | 22,198 |
| 2021-01-19 | Krieg Arthur M (Chief Scientific Officer) | Buy | 500 | 13.09 | 6,545 |
| 2021-01-14 | Chaudhary Kleem (Chief Business Officer) | Option Ex | 2,000 | 2.62 | 5,240 |
| 2020-12-29 | Krieg Arthur M (Chief Scientific Officer) | Buy | 443 | 14.16 | 6,272 |
| 2020-12-22 | Chaudhary Kleem (Chief Business Officer) | Option Ex | 4,000 | 2.62 | 10,480 |
| 2020-12-22 | Krieg Arthur M (Chief Scientific Officer) | Buy | 5,103 | 14.64 | 74,707 |
| 2020-12-16 | Krieg Arthur M (Chief Scientific Officer) | Buy | 4,805 | 14.62 | 70,249 |
| 2020-12-15 | Krieg Arthur M (Chief Scientific Officer) | Buy | 42 | 14.49 | 608 |
| 2020-08-11 | Novo Holdings A/s (10% Owner) | Buy | 500,000 | 15.00 | 7,500,000 |
| 2020-08-11 | Adelman Robert J | Buy | 200,000 | 15.00 | 3,000,000 |
| 2020-08-11 | Healy James (10% Owner) | Buy | 133,333 | 15.00 | 1,999,995 |
Insider trading activities including stock purchases, stock sales, and option exercises of CMPI listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Checkmate Pharmaceuticals, Inc. (symbol CMPI, CIK number 1651431) see the Securities and Exchange Commission (SEC) website.